1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Influenza Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Influenza Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Influenza Vaccines Market Regional Analysis
6.2 South & Central America Influenza Vaccines Market Revenue 2020-2028 (US$ Million)
6.3 South & Central America Influenza Vaccines Market Forecast Analysis
7. South & Central America Influenza Vaccines Market Analysis – by Vaccine Type
7.1 Quadrivalent Vaccines and Trivalent Vaccines
- 7.1.1 Overview
- 7.1.2 Quadrivalent Vaccines and Trivalent Vaccines: South & Central America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. South & Central America Influenza Vaccines Market Analysis – by Virus Type
8.1 Influenza Virus Type A and Influenza Virus Type B
- 8.1.1 Overview
- 8.1.2 Influenza Virus Type A and Influenza Virus Type B: South & Central America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. South & Central America Influenza Vaccines Market Analysis – by Technology
9.1 Egg-based and Cell-based
- 9.1.1 Overview
- 9.1.2 Egg-based and Cell-based: South & Central America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. South & Central America Influenza Vaccines Market Analysis – by Route of Administration
10.1 Injection and Nasal Spray
- 10.1.1 Overview
- 10.1.2 Injection and Nasal Spray: South & Central America Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. South & Central America Influenza Vaccines Market – South and Central America Analysis
11.1 Overview
11.2 South and Central America
- 11.2.1 South & Central America Influenza Vaccines Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 South & Central America Influenza Vaccines Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 Brazil:
South & Central America Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 Brazil: South & Central America Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.1.2 Brazil: South & Central America Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.1.3 Brazil: South & Central America Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.1.4 Brazil: South & Central America Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.2 Argentina:
South & Central America Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Argentina: South & Central America Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.2.2 Argentina: South & Central America Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.2.3 Argentina: South & Central America Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.2.4 Argentina: South & Central America Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.3 Rest of South and Central America :
South & Central America Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Rest of South and Central America : South & Central America Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.3.2 Rest of South and Central America : South & Central America Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.3.3 Rest of South and Central America : South & Central America Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.3.4 Rest of South and Central America : South & Central America Influenza Vaccines Market Breakdown, by Route of Administration
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 AstraZeneca
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 GlaxoSmithKline plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Mitsubishi Chemical Group Corporation
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 MYLAN N.V.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Sanofi
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 SEQIRUS
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Serum Institute of India Pvt. Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For South & Central America Influenza Vaccines Market
